Trends in Availability of Genetic Tests in the United States, 2012–2022

Globally, genetic testing has become increasingly used over the last two decades. As a result of the rapid development of genetic tests, the Genetic Testing Registry was created in the United States to provide transparent information on genetic tests and the corresponding laboratories. Using publicl...

Full description

Bibliographic Details
Main Authors: Alyssa L. Halbisen, Christine Y. Lu
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Journal of Personalized Medicine
Subjects:
Online Access:https://www.mdpi.com/2075-4426/13/4/638
_version_ 1797604777797877760
author Alyssa L. Halbisen
Christine Y. Lu
author_facet Alyssa L. Halbisen
Christine Y. Lu
author_sort Alyssa L. Halbisen
collection DOAJ
description Globally, genetic testing has become increasingly used over the last two decades. As a result of the rapid development of genetic tests, the Genetic Testing Registry was created in the United States to provide transparent information on genetic tests and the corresponding laboratories. Using publicly available data from the Genetic Testing Registry, we analyzed trends in the availability of genetic tests in the United States over the last decade. As of November 2022, a total of 129,624 and 197,779 genetic tests in the US and globally, respectively, including updated versions of previously existing tests, have been made available and submitted to the genetic testing registry. Over 90% of tests submitted to GTR are for clinical rather than research purposes. Worldwide, 1081 and 6214 new genetic tests had been made available in 2012 and in 2022, respectively. In 2012, only 607 and in 2022, 3097 new genetic tests were made available in the US, with 2016 seeing the biggest increase in availability of new tests during the study period. Over 90% of tests can be used for diagnosis. In the US, 10 of >250 laboratories account for 81% of new genetic tests in GTR. As more genetic tests become available, further international collaboration is required for a comprehensive understanding of the available genetic tests worldwide.
first_indexed 2024-03-11T04:51:34Z
format Article
id doaj.art-fbaef96684ee48baa9c684886b5e343e
institution Directory Open Access Journal
issn 2075-4426
language English
last_indexed 2024-03-11T04:51:34Z
publishDate 2023-04-01
publisher MDPI AG
record_format Article
series Journal of Personalized Medicine
spelling doaj.art-fbaef96684ee48baa9c684886b5e343e2023-11-17T19:59:59ZengMDPI AGJournal of Personalized Medicine2075-44262023-04-0113463810.3390/jpm13040638Trends in Availability of Genetic Tests in the United States, 2012–2022Alyssa L. Halbisen0Christine Y. Lu1Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston, MA 02215, USAHarvard Medical School, Harvard Pilgrim Health Care Institute, Boston, MA 02215, USAGlobally, genetic testing has become increasingly used over the last two decades. As a result of the rapid development of genetic tests, the Genetic Testing Registry was created in the United States to provide transparent information on genetic tests and the corresponding laboratories. Using publicly available data from the Genetic Testing Registry, we analyzed trends in the availability of genetic tests in the United States over the last decade. As of November 2022, a total of 129,624 and 197,779 genetic tests in the US and globally, respectively, including updated versions of previously existing tests, have been made available and submitted to the genetic testing registry. Over 90% of tests submitted to GTR are for clinical rather than research purposes. Worldwide, 1081 and 6214 new genetic tests had been made available in 2012 and in 2022, respectively. In 2012, only 607 and in 2022, 3097 new genetic tests were made available in the US, with 2016 seeing the biggest increase in availability of new tests during the study period. Over 90% of tests can be used for diagnosis. In the US, 10 of >250 laboratories account for 81% of new genetic tests in GTR. As more genetic tests become available, further international collaboration is required for a comprehensive understanding of the available genetic tests worldwide.https://www.mdpi.com/2075-4426/13/4/638genetic testinggenetic testing registrygenetic test availability
spellingShingle Alyssa L. Halbisen
Christine Y. Lu
Trends in Availability of Genetic Tests in the United States, 2012–2022
Journal of Personalized Medicine
genetic testing
genetic testing registry
genetic test availability
title Trends in Availability of Genetic Tests in the United States, 2012–2022
title_full Trends in Availability of Genetic Tests in the United States, 2012–2022
title_fullStr Trends in Availability of Genetic Tests in the United States, 2012–2022
title_full_unstemmed Trends in Availability of Genetic Tests in the United States, 2012–2022
title_short Trends in Availability of Genetic Tests in the United States, 2012–2022
title_sort trends in availability of genetic tests in the united states 2012 2022
topic genetic testing
genetic testing registry
genetic test availability
url https://www.mdpi.com/2075-4426/13/4/638
work_keys_str_mv AT alyssalhalbisen trendsinavailabilityofgenetictestsintheunitedstates20122022
AT christineylu trendsinavailabilityofgenetictestsintheunitedstates20122022